Description

The purpose of this training is to provide participants with a detailed overview of medications that have been shown to be effective as a component of the treatment of alcohol use disorder. Topics will include: the context for medications for addiction treatment (positive and negative perceptions); the epidemiology of alcohol use and alcohol use disorder; a review of each FDA-approved medication, its indication, to whom it is administered, and how it works; and treatment settings for medication for alcohol use disorder treatment. Medications will include: acamprosate, disulfiram, and naltrexone. The training will conclude with a session on talking with clients who are ambivalent about medications, and strategies to increase access and engage patients in care.

Learning Objectives

• Name at least three (3) acute and chronic effects of alcohol.
• Identify the prevalence of and list three (3) key populations impacted by alcohol
  use disorder.
• Specify three (3) medications that are available to treat alcohol use disorder.
• Apply at least two (2) strategies that can be used to increase patient engagement and access to medications for alcohol use disorder.

Presented by:

Thomas E. Freese, PhD. and Beth A. Rutkowski, MPH Thomas E. Freese, PhD., is the Director of the UCLA Integrated Substance Use and Addiction Programs (ISAP) and Adjunct Professor in the Department of Psychiatry. Additionally, he serves as Director of Training and Dissemination for the Division of Addiction Psychiatry in the David Geffen School of Medicine at UCLA, Co-Director of the SAMHSA-funded Pacific Southwest (HHS Region 9) Addictions Technology Transfer Center (PSATTC), and Co-PI of the Training and Dissemination contract with DHCS for the Recovery Incentives Program: California’s Contingency Management Benefit and with MT DPHHS for the HEART Demonstration: Montana’s Contingency Management Program. Dr. Freese conducts evidence-based trainings on a wide variety of topics including addressing the stimulant and opioid epidemics, the intersection of HIV, homelessness, and substance use, implementing integrated treatment, and implementing evidence-based treatment practices. He has been a featured presenter at conferences and meetings across the US and internationally.

Beth A. Rutkowski, MPH, has been associated with UCLA Integrated Substance Use and Addiction Programs (ISAP) since December 2000, and currently serves as the Director of Training, Co-Director of the SAMHSA-funded Pacific Southwest Addiction Technology Transfer Center, and Co-Principal Investigator of Training and Implementation Support for both the Recovery Incentives Program: California’s Contingency Management Benefit and the HEART Demonstration: Montana’s Contingency Management Program. Ms. Rutkowski leads the development of synchronous and asynchronous training and intensive technical assistance activities and products and based on evidence-based substance use disorder treatment interventions and recovery approaches and organizes and conducts conferences and trainings throughout the Pacific Southwest region (HHS Region 9, covering AZ, CA, HI, NV, and the six U.S. Affiliated Pacific Jurisdictions). She has co-authored and edited dozens of peer reviewed research articles, book chapters, special issues, and technical reports on substance use disorder treatment.

Continuing Education Units:

Certification Board Information

NAADAC (The Association for Addiction Professionals)

Qualifies for NAADAC Credit: No

NBCC (National Board for Certified Counselors)

CASAT has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6492. Programs that do not qualify for NBCC credit are clearly identified. CASAT is solely responsible for all aspects of the programs. (Continuing education hours and CEU's are synonymous for purposes of issuing CEU's from CASAT Learning) Qualifies for NBCC Credit: No

NCB (Nevada Certification Board)

Details